Recent studies suggested that Stat3 is a central regulator of the molecular link between tubular and interstitial cells during CKD progression32, and pharmacologic inhibition of Stat3 has been shown to decrease fibrotic progression in diabetes or UUO4,33. Here, STAT3 is linked to chronic kidney disease.